SpringWorks Therapeutics, Inc. Common Stock (SWTX) is a publicly traded Healthcare sector company. As of May 20, 2026, SWTX trades at $46.99 with a market cap of $3.48B and a P/E ratio of -13.78. SWTX moved +0.00% today. Year to date, SWTX is +29.45%; over the trailing twelve months it is +25.21%. Its 52-week range spans $28.21 to $62.00. Analyst consensus is buy with an average price target of $47.00. Rallies surfaces SWTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for SWTX shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $46.99 |
| Market Cap | $3.48B |
| P/E Ratio | -13.78 |
| EPS | $-3.41 |
| Dividend Yield | 0.00% |
| 52-Week High | $62.00 |
| 52-Week Low | $28.21 |
| Volume | 5.01M |
| Avg Volume | 0 |
| Revenue (TTM) | $219.67M |
| Net Income | $-253.93M |
| Gross Margin | 93.23% |
11 analysts cover SWTX: 0 strong buy, 7 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $47.00.